compounded semaglutide being discontinued (GLP-1) Important Safety Information | GoodGirlRx

Description

Preexisting history of GI motility issues (gastroparesis) Ask yourself

Any views expressed in this article reflect current scientific understanding as of the publication date and may evolve with further research

This medicine targets three hormone receptors at once: GLP-1, GIP, and GCG, which is why some call it Triple G. Trials have compared retatrutide with both placebo and other approved drugs to see how well it works and how safe it is

From venoms to drugs

Common side effects include: Nausea and vomiting Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite (which, whilst an intended effect, can occasionally be excessive) Belching or indigestion Most of these effects are mild to moderate in severity and transient